Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The thrombin generation pathway refers to the complex cascade of biochemical reactions in blood coagulation that culminates in the production of thrombin, a serine protease central to hemostasis. Thrombin is responsible for converting soluble fibrinogen into insoluble fibrin, activating platelets, and amplifying its own generation through feedback mechanisms. Dysregulation can lead to bleeding or thrombosis. The pathway involves initiation, amplification, and propagation phases, with key components like tissue factor, coagulation factors, and platelets, regulated by inhibitors and the protein C system. Dysfunction within this pathway contributes to disorders like hemophilia, thrombophilia, and sepsis-induced coagulopathy.
Varies depending on the target within the pathway and the specific drug. Examples: Inhibition of thrombin, inhibition of Factor Xa, vitamin K antagonism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thrombin Generation Pathway.